Treatment responses of four different biologics in a patient with recurrent generalized pustular psoriasis harboring IL36RN mutation
Saved in:
Main Authors: | Chang-Yu Hsieh (Author), Tsen-Fang Tsai (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted review of IL36RN mutations in patients with generalised pustular psoriasis
by: James G. Krueger, et al.
Published: (2024) -
Lack of association between mutation in IL36RN and palmoplantar pustular psoriasis in Chinese patients,
by: Yu Xiaoling, et al.
Published: (2020) -
The utility of IL36RN mutation analysis in an elderly patient with generalized pustular psoriasis patient treated with secukinumab
by: Satoko Minakawa, et al.
Published: (2023) -
A Case of Old Age-Onset Generalized Pustular Psoriasis with a Deficiency of IL-36RN (DITRA) Treated by Granulocyte and Monocyte Apheresis
by: Chiharu Tominaga, et al.
Published: (2015) -
New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors
by: João Vilaça, et al.
Published: (2024)